23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron
92 comments
·May 19, 2025yawnxyz
slg
Which somewhat undermines all the doomsday scenarios that people have been talking about. Going back to 23andMe going bankrupt in the first place, this data is clearly not worth nearly as much as it would be if any potential buyers thought there was an actual legal path to abusing this data in the way many are predicting. That doesn't mean that won't change in the future and part of the problem here is that there is no putting the toothpaste back in the tube, but buyers don't think this will change anytime soon, which should be an indication that it probably won't.
nextos
DeCODE, which was a very fancy Icelandic company roughly in the same niche as 23andme (founded in the 1990s!), also got bought by a pharma. Amgen in their case. For more background, see: https://en.wikipedia.org/wiki/DeCODE_genetics.
Genetic information is valuable for finding drug targets, but it's generally a poor predictor of disease, except in case of rare monogenic disorders. With the advent of large population studies such as UK Biobank, which include lots of epigenetic information as well, I am not sure if one can get much extra value from 23andme's dataset in a pharmaceutical context.
lesuorac
Idk.
Everybody made fun of Elon buying twitter but the spin-off from it (X.ai) was valued enough to buy the original company.
We'll need to wait a bunch of more years to see if the 23andme concerns were unfounded.
mgiampapa
Those are all paper transactions with made up numbers. You need outside money coming in from sane investors for the numbers to mean things.
bflesch
They will keep selling and re-selling copies of this dataset as long as there are interested buyers.
pavel_lishin
There may be some sort of exclusivity clause that comes with the sale - though, of course, that's no guarantee of anything.
xxpor
Does the first sale doctrine apply to B2B?
1vuio0pswjnm7
Licensing, not selling.
benrapscallion
That’s not what has been happening with DiscovEHR and Regeneron Genetics Center data.
davidcbc
So far
shadowgovt
So the database of DNA will continue to be copied, and copied, and copied...
Life, uh, really does find a way!
xyst
There is no "better outcome".
People who got bamboozled into paying for this junk service shouldn’t have their DNA data treated as some commodity that can be traded like a stock.
The sale of this data should be treated as PII and "transfers of ownership" should not be implied. The default for every user should be to delete the data upon sale of company and provide a way for users to opt in to the transfer.
Users should be incentivized and trust (if any at this point) needs to be rebuilt with this new company, not implied.
bananalychee
I paid for a service that gave me useful insights into my ancestry and health profile, and it cost me less than 30 minutes with a teledoc and a basic blood test. I opted out of keeping my sample in storage and using the data for research at the time, and deleted my account and data a few months ago as a matter of general digital hygiene, but even if they didn't honor any of that, I don't see why I should be concerned about it being out there. The privacy concerns were quite obvious and oft-discussed several years ago when I sent my sample in, so I certainly didn't get "bamboozled". I'm sure there are many people who didn't consider that their data may not be private, but how many actually care about that?
JonChesterfield
The ones that are reliant on health insurance to not die and now can't have any because their genotype suggests they might be expensive?
SlightlyLeftPad
I sense a lawsuit incoming that could lead to a supreme court decision on the basis of this being medical data, who actually owns that data? It really isn’t 23andme’s dna to sell to the highest bidder, it’s the customer’s protected health data, and would fall under HIPAA.
criddell
[delayed]
malfist
With this corporatist court? You'd be lucky if they don't reverse the ban on using the data for health insurance and all privacy laws at the same time
westmeal
You're making too much sense
butlike
I Want To Believe.
rudedogg
Not sure if it's still the same procedure as in March, but if you haven't done it already: https://www.eff.org/deeplinks/2025/03/how-delete-your-23andm...
jungturk
It is - just followed these steps this week.
As noted therein, you need to request a download well before you actually delete your account, since the former requires to batch work to complete and the latter will cancel any in-progress requests.
blitzar
> Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.
Some juicy data they sold there.
solarkraft
$17 per person. quite a number.
wiether
And to think that most of those 15 million people even gave their own money so that 23&Me could sold them for that price later on!
micromacrofoot
They weren't donations, 23andMe provided a service people thought was worth it at the time of purchase
florbnit
To be fair most people got their results 17$ cheaper than it would have cost them if the data hadn’t been stored to later be sold /s
azan_
$256 is steal for what they are getting.
usaphp
There was a checkbox about letting 23andme use your dna in research, I wonder if that will be forced to be respected by regeneron after a sale?
hiatus
It's crazy that your own genome is not protected health information. Your doctor can't just sell your info to another doctor when they close their practice.
epistasis
Your doctor can sell your data at any time into health data markets as long as their privacy policy allows it, and many do. See this article from 2016, for example:
https://www.scientificamerican.com/article/how-data-brokers-...
Optum Health and IQVIA facilitate this.
Additionally, 23andMe sold data in the past, quite publicly, to pharma companies to help identify drug targets.
My biggest concern, more than the trading of health data and genomes, is that people are not away its happening. That builds distrust. The actual practice of sharing deidentified health data helps improve outcomes and lower costs, aid discovery, etc. etc. But if people don't know it's happening they may get scared and try to stop it, without fully understanding the risks and benefits and how the risks have been mitigated by current law.
I 23andMe delete my data a while back. I argued with people on online forums about it in two different directions: 1) that 23andMe actually would delete your data so go ahead and request it to be deleted, it's not a futile effort, and 2) it's not super important. I did it mostly because I intensely dislike the behavior of 23andMe leadership, and secondarily because it may have ended up in more nefarious hands. Which leads to 3) the most dangerous use of this data is in bad science from bad polygenic risk scores, which have been a big fad for the past few years, but which are also extremely easy to mess up. Discrimination based on bad models with poor results is just as harmful as discrimination based on good models with adequate results, and some might even say worse.
RandallBrown
They can't sell the info, but they can sell the practice, which is very similar.
throwaway173738
They do put the records in the care of another practice at times. My dentist did that when he retired.
dannykwells
This is honestly a fantastic outcome.
Regeneron is among the most science and data focused biopharma and has a long, long history in genetics. They know how critical privacy is and will ensure the data are used to advance human health.
Potentially an even better home for the data than in the company, since now will not have pressure of quarterly reports.
jadbox
On the face of it, this seems like a win-win when you think about Regeneron using this data to make better medicines based on the data.
Ylpertnodi
Oh, now i feel better. They're trustworthy. Got it.
tgv
And it's now worth more to aggressive buyers.
xyst
This was the same sentiment about 23andme many years ago.
If regeneron cared about user privacy, then they would work to make sure consent to use of every piece of data is obtained.
It should be the default to delete any data that has not received a consent upon transfer and users must opt in for regeneron to use it for research or otherwise.
cess11
If they cared about "privacy" in the sense of data protection rights they wouldn't be based in the US.
hermannj314
Telling the slave how lucky he is to have been bought by a good slave owner.
Buying and selling humans has never been a good thing. Trading their DNA in the marketplace without consent is just the new evil our generation is too blind to see.
rolisz
Are there any "safer" options for doing genetic testing? From a privacy perspective mostly.
mylons
not really. i work in the field. any commercial offering is likely subject to this. every company i've worked for that does personal testing eventually gives their data to someone: other companies, or law enforcement.
it's even worse if one of your siblings or close relatives does this. people have been implicated in crimes due to relatives getting tested. on the one hand that's great they're closing cold cases, but the disaster where this is used incorrectly against you is horrifying.
tantalor
I'd argue that even using the gene database to correctly nab wrongdoers is horrifying.
The ends do not justify the means. The police should not have an easily searchable database of everyone's genetic profile, no matter how they gathered it.
mylons
i agree with you
drdaeman
Does it mean that no company honestly offers a "we sequence your generic material, send you data back, and completely forget the whole affair afterwards, all genetic data wiped on our side with the only copy left being yours - no strings attached" type of service? In a jurisdiction that doesn't require labs to retain anything (so non-US, as US has CLIA). I assume it would cost significantly more than usual subscription/research-subsidized services, of course.
I'm not interested in services of finding relatives or health coach gimmicks, I just want an one-time purchase of a raw data blob with solid personal privacy guarantees. Am I asking for too much?
mylons
as far as i know this is not offered. my assumption is there's little to no demand. if there is a ton of demand, i'd be happy to start this company :)
FL33TW00D
Why isn't there a company that just "wraps" Illumina. Zero partners minus the Illumina machine. Seems obvious.
mylons
what do you mean? i think you more or less described every personal genetics testing company as they start out. they use the illumina machine to do the testing and develop custom assays with said machine
bflesch
So I have to assume my DNA data was illegally sold by 23andme to Regeneron.
In return, I just asked Regeneron to provide me a copy of sequenced DNA data from their CEO and founder. As Regeneron seems to be cool with buying and selling of DNA data they should not have a problem to share their leadership's DNA.
epistasis
What do you mean by "illegal"?
JonChesterfield
Need to offer $17 for it
Considering the long list of awful pharma, insurance, and marketing firms in the world out there, Regeneron is probably one of the better outcomes